Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

Quantinuum may not be a household name yet, and it’s not even publicly traded, but it has quickly become one of the most ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.

According to Gary Russo, Executive Director of Workforce Intelligence at Providence Health & Services, "Bringing together people analytics and skills data will help us innovate in our sourcing and ...

SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology ...

The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in ...

Amgen and UCB finally have FDA approval for ... blocking the effects of the protein sclerostin and as a consequence building new bone formation. However it has been approved with a narrower ...

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying ... but sales have yet to gather much momentum. Amgen reported yesterday that full-year 2023 sales of Lumakras ...

In fact, pharma giant Amgen is already working with Quantinuum ... Quantinuum is quietly building the foundation for the quantum revolution. Even without a stock ticker (for now), this company ...

Here are Columbus CEO ’s 2025 Top Workplaces winners: Worthington Steel President and CEO Geoff Gilmore (third from left) ...